- Lobbying
- Lobbying by Bose Corporation
Lobbying Relationship
Bills mentioned
H.R.1652: Over-the-Counter Hearing Aid Act of 2017
Sponsor: Joseph P. Kennedy III (D-Mass.)
S.670: Over-the-Counter Hearing Aid Act of 2017
Sponsor: Elizabeth Warren (D-Mass.)
H.R.5376: Inflation Reduction Act of 2022
Sponsor: John Yarmuth (D-Ky.)
H.R.3: Elijah E. Cummings Lower Drug Costs Now Act
Sponsor: Frank Pallone (D-N.J.)
S.4338: Increasing Transparency in Generic Drug Applications Act
Sponsor: Margaret Hassan (D-N.H.)
S.4043: Delivering Over-the-Counter Hearing Aids Now Act
Sponsor: Elizabeth Warren (D-Mass.)
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist | Covered positions? |
---|---|
Barry Brown | Chief of Staff, Rep. Michael Burgess & Rep. Kay Granger; Legislative Director, Rep. Kevin Brady Chief of Staff, Rep. Michael Burgess & Rep. Kay Granger; Legislative Director, Rep. Kevin Brady |
J. Michael Hogan | Deputy Chief of Staff, Sen. Ben Nelson |
James Hawkins III | Health Policy Advisor, Senate HELP Committee |
Courtney Johnson | Research Assistant, House Energy & Commerce Committee |
Kelsey Marx | n/a |
James Hawkins | n/a |
JAY HAWKINS | n/a |
Mike Hogan | n/a |
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
U.S. House of Representatives
Food & Drug Administration (FDA)
U.S. House of Representatives
U.S. House of Representatives
Food & Drug Administration (FDA)
U.S. House of Representatives
U.S. House of Representatives
Food & Drug Administration (FDA)
U.S. House of Representatives
U.S. House of Representatives
Food & Drug Administration (FDA)
U.S. House of Representatives
U.S. House of Representatives
Food & Drug Administration (FDA)
U.S. House of Representatives
U.S. House of Representatives
Food & Drug Administration (FDA)
U.S. House of Representatives
Food & Drug Administration (FDA)
U.S. House of Representatives
Food & Drug Administration (FDA)
U.S. House of Representatives
U.S. House of Representatives
Food & Drug Administration (FDA)
U.S. House of Representatives
Food & Drug Administration (FDA)
U.S. House of Representatives
Food & Drug Administration (FDA)
U.S. House of Representatives
Food & Drug Administration (FDA)
U.S. House of Representatives
Food & Drug Administration (FDA)
U.S. House of Representatives
Food & Drug Administration (FDA)
U.S. House of Representatives
Food & Drug Administration (FDA)
U.S. House of Representatives
Food & Drug Administration (FDA)
U.S. Senate
U.S. House of Representatives
Food & Drug Administration (FDA)
U.S. Senate
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate